Theseus Pharmaceuticals Story
THRXDelisted Stock | USD 4.06 0.00 0.00% |
Slightly above 56% of Theseus Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in Theseus Pharmaceuticals suggests that many traders are alarmed regarding Theseus Pharmaceuticals' prospects. Theseus Pharmaceuticals' investor sentiment overview provides quick insight into current market opportunities from investing in Theseus Pharmaceuticals. The current market sentiment, together with Theseus Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Theseus Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Theseus Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Theseus daily returns and investor perception about the current price of Theseus Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Theseus |
Requested story not found. it has been either deleted or moved. View all stories for Theseus Pharmaceuticals.
Theseus Pharmaceuticals Latest Timeline
Theseus Pharmaceuticals is listed for 4.06. About 93.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.81. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Theseus Pharmaceuticals has Price/Earnings (P/E) ratio of 737.67. The entity recorded a loss per share of 1.34. The firm last dividend was issued on the September 8, 2015. Theseus Pharmaceuticals had 1241:1000 split on the June 3, 2014.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Theseus Stock
If you are still planning to invest in Theseus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Theseus Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |